Skip to main content
. 2018 Jan 25;124(8):1701–1709. doi: 10.1002/cncr.31251

Figure 3.

Figure 3

Survival stratified by radiographic response is illustrated in (A) cohort 1 (standard chemoradiation [ChemoRT]), (B) cohort 2 (metastatic pancreatic ductal adenocarcinoma [PDAC]), (C) cohort 3 (protocol‐based gemcitabine plus chemoRT [GemRT]), and (D) cohort 4 (registry trial).